Literature DB >> 10710533

P. carinii induces selective alterations in component expression and biophysical activity of lung surfactant.

E N Atochina1, M F Beers, S T Scanlon, A M Preston, J M Beck.   

Abstract

Studies of Pneumocystis carinii pneumonia (PCP) suggest an important role for the surfactant system in the pathogenesis of the hypoxemic respiratory insufficiency associated with this infection. We hypothesized that PCP induces selective alterations in alveolar surfactant component expression and resultant biophysical properties. PCP was induced by intratracheal inoculation of 2 x 10(5) P. carinii organisms into C.B-17 scid/scid mice. Six weeks after inoculation, large (LA)- and small (SA)-aggregate surfactant fractions were prepared from bronchoalveolar lavage fluids and analyzed for expression of surfactant components and for biophysical activity. Total phospholipid content was significantly reduced in LA surfactant fractions from mice infected with PCP (53 +/- 15% of uninfected mice; P < 0.05). Quantitation of hydrophobic surfactant protein (SP) content demonstrated significant reductions of alveolar SP-B and SP-C protein levels in mice with PCP compared with those in uninfected mice (46 +/- 7 and 19 +/- 6%, respectively; P < 0.05 for both). The reductions in phospholipid, SP-B, and SP-C in LA fractions measured during PCP were associated with an increase in the minimum surface tension of LAs as measured by pulsating bubble surfactometer (13.1 +/- 1.1 vs. 5.4 +/- 1.8 mN/m; P < 0.05). In contrast to decreases in the hydrophobic SPs, SP-D content in the SA fraction was markedly increased (343 +/- 30% of control value; P < 0. 05) and SP-A levels in LA surfactant were maintained (93 +/- 26% of control value) during P. carinii infection. In all cases, the changes in SP content were reflected by commensurate changes in the levels of mRNA. We conclude that PCP induces selective alterations in surfactant component expression, including profound decreases in hydrophobic protein contents and resultant increases in surface tension. These changes, demonstrated in an immunologically relevant animal model, suggest that alterations in surfactant could contribute to the hypoxemic respiratory insufficiency observed in PCP.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10710533     DOI: 10.1152/ajplung.2000.278.3.L599

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  18 in total

Review 1.  Pneumocystis.

Authors:  Francis Gigliotti; Andrew H Limper; Terry Wright
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

Review 2.  Current understanding of Pneumocystis immunology.

Authors:  Michelle N Kelly; Judd E Shellito
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

3.  Pulmonary inflammation disrupts surfactant function during Pneumocystis carinii pneumonia.

Authors:  T W Wright; R H Notter; Z Wang; A G Harmsen; F Gigliotti
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

4.  Lung surfactant protein D (SP-D) response and regulation during acute and chronic lung injury.

Authors:  Maria Quisgaard Gaunsbaek; Karina Juhl Rasmussen; Michael F Beers; Elena N Atochina-Vasserman; Soren Hansen
Journal:  Lung       Date:  2013-02-24       Impact factor: 2.584

5.  Alveolar surfactant protein D content modulates bleomycin-induced lung injury.

Authors:  John Casey; Jennifer Kaplan; Elena N Atochina-Vasserman; Andrew J Gow; Helchem Kadire; Yaniv Tomer; James H Fisher; Samuel Hawgood; Rashmin C Savani; Michael F Beers
Journal:  Am J Respir Crit Care Med       Date:  2005-06-30       Impact factor: 21.405

6.  Early alveolar epithelial dysfunction promotes lung inflammation in a mouse model of Hermansky-Pudlak syndrome.

Authors:  Elena N Atochina-Vasserman; Sandra R Bates; Peggy Zhang; Helen Abramova; Zhenguo Zhang; Linda Gonzales; Jian-Qin Tao; Bernadette R Gochuico; William Gahl; Chang-Jiang Guo; Andrew J Gow; Michael F Beers; Susan Guttentag
Journal:  Am J Respir Crit Care Med       Date:  2011-08-15       Impact factor: 21.405

7.  Defective surfactant secretion in a mouse model of Hermansky-Pudlak syndrome.

Authors:  Susan H Guttentag; Amana Akhtar; Jian-Qin Tao; Elena Atochina; Michael E Rusiniak; Richard T Swank; Sandra R Bates
Journal:  Am J Respir Cell Mol Biol       Date:  2005-03-24       Impact factor: 6.914

Review 8.  Surfactant therapy for acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; D Willson; R H Notter
Journal:  Crit Care Clin       Date:  2011-07       Impact factor: 3.598

9.  Pneumocystis pneumonia increases the susceptibility of mice to sublethal hyperoxia.

Authors:  James M Beck; Angela M Preston; Steven E Wilcoxen; Susan B Morris; Eric S White; Robert Paine
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

10.  Immune reconstitution during Pneumocystis lung infection: disruption of surfactant component expression and function by S-nitrosylation.

Authors:  Elena N Atochina-Vasserman; Andrew J Gow; Helen Abramova; Chang-Jiang Guo; Yaniv Tomer; Angela M Preston; James M Beck; Michael F Beers
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.